Quillivant XR (methylphenidate extended release oral suspension) / Pfizer 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Quillivant XR (methylphenidate extended release oral suspension) / Pfizer
DS+ADHD Pilot, NCT04219280: Evaluating Treatment of ADHD in Children With Down Syndrome

Recruiting
4
100
US
Quillivant XR, Placebo
Children's Hospital Medical Center, Cincinnati, University of California, Davis
Down Syndrome, ADHD
09/25
09/25
NCT04419272 / 2012-004406-10: Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

Recruiting
4
226
US
Methylphenidate, Concerta, Ritalin, Daytrana, Aptensio XR, Metadate CD, Methylin, Quillivant XR, Jornay PM, Adhansia XR, Cotempla, Placebo, sugar pill, lactose
VA Office of Research and Development, VA New York Harbor Healthcare System, Portland VA Medical Center, Miami VA Healthcare System, VA Boston Healthcare System
Epilepsy
09/27
09/27
NCT01628029: Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

Active, not recruiting
2
68
US
Counseling, Counseling Intervention, Methylphenidate Hydrochloride, Concerta, Quillivant XR, Ritalin, Phototherapy, Actinotherapy, Bright Light Therapy, light therapy, Placebo Administration, Quality-of-Life Assessment, Quality of Life Assessment, Sham Intervention, Sham Comparator, Therapeutic Melatonin, Circadin, Melatonin, Melaxen
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Sleep Disorder
12/25
12/25

Download Options